Doctors use experimental drug to cure baby with genetic disorder

11/5/2009 | Google

Doctors said they successfully cured an Australian baby with molybdenum cofactor deficiency, a genetic disorder that could lead to seizures and brain damage, with an experimental drug that has been tested only in mice. The treatment, cyclic pyranopterin monophosphate, reportedly stabilized the baby's sulphite levels, a significant factor in the disease.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC